| Old Articles: <Older 45911-45920 Newer> |
|---|
 |
The Motley Fool
December 9, 2010
Seth Jayson |
Affymetrix Passes This Key Test By considering the trends in accounts receivable and days sales outstanding we can get a window into Affymetrix's future.   |
The Motley Fool
December 9, 2010
Lomax & Yochim |
Stock Picks With Chicks: Estee Lauder's Fresh Face We want a company whose good looks are more than skin deep. And in the cosmetics space, that company is Estee Lauder. |
The Motley Fool
December 9, 2010
Dan Caplinger |
How Spinoffs Can Make You Rich Spinoffs can be a great way to unlock shareholder value -- sometimes. |
The Motley Fool
December 9, 2010
Seth Jayson |
Don't Get Too Worked Up Over Talecris Biotherapeutics' Earnings With 13.9% of operating cash flow coming from questionable sources, Talecris Biotherapeutics investors should take a closer look at the underlying numbers. |
The Motley Fool
December 9, 2010
Seth Jayson |
Here's How Advanced Semiconductor Engineering May Be Failing You With recent TTM operating margins below historical averages, Advanced Semiconductor Engineering has some work to do. |
The Motley Fool
December 9, 2010
Rick Aristotle Munarriz |
Before You Bail on Netflix CFO Barry McCarthy thinks you shouldn't bet against Netflix this quarter. |
The Motley Fool
December 8, 2010
Selena Maranjian |
Invest Where Items Are Flying Off the Shelves Keep track of inventory to find winning stocks. |
The Motley Fool
December 8, 2010
Anders Bylund |
RIM CEO Opens Mouth, Inserts Foot We are done giving second chances to this flailing, sinking enterprise and its leaders. |
The Motley Fool
December 8, 2010
Rich Smith |
Big Brother Dumps Big Banking But that doesn't mean Citigroup won't go higher. |
The Motley Fool
December 8, 2010
Jim Mueller |
Rising Star Buy: Transocean, Again The Rising Star real money portfolio has expanded its position in Transocean as expectations remain low and risk declines. |
| <Older 45911-45920 Newer> Return to current articles. |
